Modern medicine has made tremendous strides in fighting infectious diseases, but there is much more work to be done. Every year, influenza strikes millions of people, many of them fatally. Whooping cough and measles have made a comeback as the number of people who refuse to vaccinate their children grows. One third of the world’s population is infected with latent tuberculosis. Without treatment, about 5 to 10 percent of infected people will develop TB disease at some time in their lives.
Meanwhile, the SARS-CoV-2 pandemic is sweeping the globe, taking the lives of hundreds of thousands. La Jolla Institute, one of the leading global organizations dedicated to studying the immune system, is stepping up to provide much needed information and real solutions for the ongoing COVID-19 pandemic. We have launched a multi-lab Coronavirus Taskforce that capitalizes on our competitive advantages of unique skill in infectious disease research, state-of-the-art technology and highly collaborative organization to respond to the current crisis and prepare for future emerging diseases. Our other work on HIV, Ebola, Dengue, Zika, and Cytomegalovirus are further laying the groundwork for developing vaccines for these serious infections.